First-in-human dose-escalation study of NBF-006, a novel investigational siRNA targeting GSTP, in patients with non-small cell lung, pancreatic, or colorectal cancer. Meeting Abstract (Web of Science)

cited authors

  • Tolcher, Anthony W.; Spira, Alexander I.; Nemunaitis, John J.; Vandross, Andrae Lavon; Mamdani, Hirva; O'Brien, Zhihong; Huynh, Annie; Albaugh, Zachary; Gullbo, Joachim; Zabludoff, Sonya

publication date

  • June 1, 2023

webpage

published in

category

volume

  • 41

issue

  • 16